[Skip navigation] FDA Logo links to FDA home page
Center for Drug Evaluation and Research, U.S. Food and Drug AdministrationU.S. Food and Drug AdministrationCenter for Drug Evaluation and Research
  HHS Logo links to Department of Health and Human Services website

FDA Home Page | CDER Home Page | CDER Site Info | Contact CDER | What's New @ CDER

horizonal rule
CDER Home About CDER Drug Information Regulatory Guidance CDER Calendar Specific Audiences CDER Archives
 
Powered by Google
 
 CderLearn

CDERLearn Home

Activity Description

Learning Objectives

General Instructions

Start the Activity for Credit

Accreditation

Disclosure

CE Statements of Credit/Certificate of Completion (non-CE)

Speaker Biographies

Activity Time

Replacement of CE Statement of Credit/Certificate of Completion (non-CE)

Free Registration

Privacy Policy

Download PDF Slides (694 KB; 68 pages)

Download Presentation Transcript

 

An Introduction to the Improved FDA Prescription Drug Labeling

About This Site: The FDA has contracted development and management of this educational activity. FDA’s privacy policy applies while you are on this site.
Registration: You can do this training activity without registering. However, you must register to get credit and a continuing education certificate. This is required by accrediting associations and will not be released to anyone else.

Activity Description

Welcome to the Food and Drug Administration, Center for Drug Evaluation and Research's educational activity entitled, "An Introduction to the Improved FDA Prescription Drug Labeling." This activity is designed to give you a better understanding of the revised prescription drug labeling, the format changes that were made, and why they were necessary. You will also learn about other labeling initiatives that have brought the FDA into the 21st century of promoting and protecting the health of the American people. The goal of this activity is to make information about the revised labeling clearer and more easily understood.

Learning Objectives

Upon completion of this activity, the participant will be able to:

  • Describe prescription drug labeling and related FDA requirements.
  • Describe the history of the drug labeling initiative.
  • Describe the staged implementation schedule for the revised prescription drug labeling.
  • Describe the major content and format changes to prescription drug labeling and the rationale for the changes.
  • Describe other related FDA electronic labeling initiatives.

Back to Top

General Instructions (Plugins, Audio)

Plugins - If you do not currently have the Adobe Flash Player and/or the Adobe Reader installed on your computer, you can click the appropriate link to launch the download page in a new window.

Audio - Before entering the activity, turn on your computer's speakers.

Back to Top

Start the Activity for Credit

Participants wishing to receive documented credit for taking the Web-based Activity must:

to top arrow Back to Top     back arrow Back to CDERLearn

PDF document PDF requires the free Adobe Acrobat Reader

Date created: December 3, 2007

horizonal rule